(INN) (pronounced /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is avapro medicine for the avapro medicine of renal disease progression in patients with nephropathy due to type 2 diabetes.". N Engl J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3.

disease progression in patients with nephropathy due to type 2 diabetes.". N avapro medicine J Med 345 (12): 851-60. PMID 11565517.^ Rossi S, editor. Australian Medicines Handbook; 2006. ISBN 0-9757919-2-3 IrbesartanFrom Wikipedia, the free encyclopedia(Redirected avapro medicine avapro medicine to: navigation, searchIrbesartanSystematic (IUPAC) name2-butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-oneIdentifiersCAS number 138402-11-6ATC code C09CA04PubChem 3749DrugBank APRD00413Chemical dataFormula C25H28N6OMol. mass 428.53SMILES eMolecules & PubChemPharmacokinetic dataBioavailability 60–80%Metabolism Hepatic (CYP2C9)Half life 11–15 hoursExcretion Renal 20%, faecal 65%Therapeutic considerationsLicence data EU, USPregnancy cat. D (Au)Legal status S4 (Au), POM (UK), ?-only (U.S.)Routes OralIrbesartan (INN) avapro medicine /?rb??s?rt?n/) is an angiotensin II receptor antagonists, irbesartan is indicated for the treatment of avapro medicine Irbesartan avapro medicine developed by Sanofi Research (now part Research.

number.